Masaki Hosogane

1.2k citations
10 papers · 811 indexed · 1 hit paper · h-index 7

Masaki Hosogane

10 papers receiving 809 citations

Hit Papers

Acetylation of Cytidine in mRNA Promotes Translation Effi...5662018202620202023100200300400500

Peers

Masaki Hosogane
Comparison fields: 5 of 70
  • Cancer Research 231
  • Molecular Biology 753
  • Energy Engineering and Power Technology 15
  • Oncology 74
  • Immunology 37
Replace Kyster K. Nanan with:
Kyster K. Nanan United States
Nastasja Kreim Germany
Tina Lenče Germany
Tomasz Chełmicki Germany
Yuen Gao China
Xiao Albert Zhou China
Anja S. Knaupp Australia
Martyna Popis United Kingdom
Kevin Grosselin France
Madhu Lal United States
Masaki Hosogane relative to Kyster K. Nanan United States Kyster K. Nanan's profile →
Citations per field
00.5×1.5×
Kyster K. Nanan · 1×
Citations per year

Countries citing papers authored by Masaki Hosogane

Since Specialization
Citations

This map shows the geographic impact of Masaki Hosogane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hosogane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hosogane more than expected).

Fields of papers citing papers by Masaki Hosogane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Hosogane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hosogane. The network helps show where Masaki Hosogane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masaki Hosogane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masaki Hosogane Line = papers co-authored together Masaki Hosogane links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 20251
2 20251
3 20227
4 2022102
5
Acetylation of Cytidine in mRNA Promotes Translation Efficiencybreakdown →
2018566
6 20176
7 201712
8 201653
9 201338
10 201225

About Masaki Hosogane

Masaki Hosogane is a scholar working on Immunology and Allergy, Molecular Biology and Oncology, having authored 10 papers that have together received 811 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (2 papers), Cancer-related gene regulation (2 papers), RNA and protein synthesis mechanisms (2 papers), RNA Research and Splicing (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (231 citations), Molecular Biology (753 citations) and Energy Engineering and Power Technology (15 citations). Masaki Hosogane has collaborated with scholars based in Japan and United States. Frequent co-authors include Daniel Arango, David Sturgill, Shalini Oberdoerffer, Thomas Zengeya, Stephen D. Fox, Jeff Coller, Najwa Alhusaini, Gavin Hanson, Jordan L. Meier and Kyster K. Nanan. Their work appears in journals such as Cell, Molecular Cell and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026